tirzepatide malta Lilly's Mounjaro receives FDA approval for type 2 diabetes treatment Mounjaro (Tirzepatide): Raising the Bar

The target is metabolic: insulin sensitivity, visceral and liver fat, lipids, the markers of metabolic health rather than a number on the scale

Both drugs have been shown in clinical trials to help reduce body weight significantly due to their ability to lower set points - essentially changing your body's "normal" weight - and reduce hunger sensations

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society, Obesity Pillars

Lymphedema is a chronic condition characterized by abnormal accumulation of protein-rich fluid in the interstitial tissues, resulting in progressive swelling, typically affecting the extremities

Lifestyle coaching helps amplify your results

Amino acid synthesis deficiencies